Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
[11]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006
[12]   Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart [J].
Gilbert, EM ;
Abraham, WT ;
Olsen, S ;
Hattler, B ;
White, M ;
Mealy, P ;
Larrabee, P ;
Bristow, MR .
CIRCULATION, 1996, 94 (11) :2817-2825
[13]  
Gilbert R, 1999, J CELL SCI, V112, P69
[14]   Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy [J].
Kimura, A ;
Harada, H ;
Park, JE ;
Nishi, H ;
Satoh, M ;
Takahashi, M ;
Hiroi, S ;
Sasaoka, T ;
Ohbuchi, N ;
Nakamura, T ;
Koyanagi, T ;
Hwang, TH ;
Choo, TA ;
Chung, KS ;
Hasegawa, A ;
Nagai, R ;
Okazaki, O ;
Nakamura, H ;
Matsuzaki, M ;
Sakamoto, T ;
Toshima, H ;
Koga, Y ;
Imaizumi, T ;
Sasazuki, T .
NATURE GENETICS, 1997, 16 (04) :379-382
[15]   ASSEMBLY OF CARDIAC C-PROTEIN DURING MYOFIBRILLOGENESIS IN MYOGENIC CELLS IN CULTURE [J].
KOSHIDA, S ;
KURASAWA, M ;
YASUDA, M ;
SATO, N ;
OBINATA, T .
CELL STRUCTURE AND FUNCTION, 1995, 20 (04) :253-261
[16]   RESULTS OF SCREENING A LARGE GROUP OF INTERCOLLEGIATE COMPETITIVE ATHLETES FOR CARDIOVASCULAR-DISEASE [J].
MARON, BJ ;
BODISON, SA ;
WESLEY, YE ;
TUCKER, E ;
GREEN, KJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (06) :1214-1221
[17]   PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY IN A GENERAL-POPULATION OF YOUNG-ADULTS - ECHOCARDIOGRAPHIC ANALYSIS OF 4111 SUBJECTS IN THE CARDIA STUDY [J].
MARON, BJ ;
GARDIN, JM ;
FLACK, JM ;
GIDDING, SS ;
KUROSAKI, TT ;
BILD, DE .
CIRCULATION, 1995, 92 (04) :785-789
[18]   α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy [J].
Mogensen, J ;
Klausen, IC ;
Pedersen, AK ;
Egeblad, H ;
Bross, P ;
Kruse, TA ;
Gregersen, N ;
Hansen, PS ;
Baandrup, U ;
Borglum, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :R39-R43
[19]   A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance [J].
Moolman, JA ;
Reith, S ;
Uhl, K ;
Bailey, S ;
Gautel, M ;
Jeschke, B ;
Fischer, C ;
Ochs, J ;
McKenna, WJ ;
Klues, H ;
Vosberg, HP .
CIRCULATION, 2000, 101 (12) :1396-1402
[20]   Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy [J].
Moolman-Smook, JC ;
Mayosi, B ;
Brink, P ;
Corfield, VA .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) :253-254